Ameriprise sells 4.8% 2031 and 5.35% 2036 notes
Ameriprise Financial, Inc. issued $300,000,000 of 4.800% Senior Notes due 2031 and $450,000,000 of 5.350% Senior Notes due 2036.
Rhea-AI Filing Summary
Ameriprise Financial, Inc. issued $300,000,000 of 4.800% Senior Notes due 2031 and $450,000,000 of 5.350% Senior Notes due 2036. These notes were sold to underwriters led by BofA Securities, Citigroup Global Markets, and J.P. Morgan Securities under an underwriting agreement dated June 4, 2026.
The notes were offered using a prospectus supplement dated June 4, 2026 to a February 23, 2024 prospectus, both under the company’s shelf registration statement on Form S-3. Related documents, including the forms of the notes, the underwriting agreement, and a legal opinion from Faegre Drinker Biddle & Reath LLP, were filed as exhibits.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
2031 Senior Notes: $300,000,000 principal, 4.800% coupon
2036 Senior Notes: $450,000,000 principal, 5.350% coupon
Shelf registration: Form S-3, No. 333-277307
+1 more
4 metrics
2031 Senior Notes
$300,000,000 principal, 4.800% coupon
4.800% Senior Notes due 2031 issued June 9, 2026
2036 Senior Notes
$450,000,000 principal, 5.350% coupon
5.350% Senior Notes due 2036 issued June 9, 2026
Shelf registration
Form S-3, No. 333-277307
Prospectus dated February 23, 2024
Prospectus supplement date
June 4, 2026
Supplement governing the notes offering
Key Terms
Senior Notes, Underwriting Agreement, prospectus supplement, registration statement on Form S-3, +1 more
5 terms
Senior Notes financial
"4.800% Senior Notes due 2031 and 5.350% Senior Notes due 2036"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
Underwriting Agreement financial
"sold pursuant to the Underwriting Agreement that the Company entered into on June 4, 2026"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
prospectus supplement regulatory
"offered pursuant to the prospectus supplement dated June 4, 2026, to the prospectus dated February 23, 2024"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
registration statement on Form S-3 regulatory
"filed with the Securities and Exchange Commission as part of the Company’s registration statement on Form S-3"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
aggregate principal amount financial
"issued $300,000,000 aggregate principal amount of its 4.800% Senior Notes"
The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ameriprise Financial (AMP) disclose in this Form 8-K?
Ameriprise Financial disclosed it issued two new series of senior notes: $300,000,000 of 4.800% notes due 2031 and $450,000,000 of 5.350% notes due 2036, sold through a syndicate of underwriters under a June 4, 2026 underwriting agreement.
What are the key terms of Ameriprise Financial’s 4.800% Senior Notes due 2031?
The 2031 notes have an aggregate principal amount of $300,000,000 and a 4.800% interest rate. They are senior unsecured obligations of Ameriprise Financial, issued on June 9, 2026, and offered under a prospectus supplement tied to the company’s Form S-3 shelf registration statement.
What are the key terms of Ameriprise Financial’s 5.350% Senior Notes due 2036?
The 2036 notes have an aggregate principal amount of $450,000,000 and a 5.350% interest rate. They are senior obligations due in 2036, issued on June 9, 2026, and were offered under a June 4, 2026 prospectus supplement to Ameriprise’s existing Form S-3 registration.
Which underwriters handled Ameriprise Financial’s new senior notes offering?
BofA Securities, Inc., Citigroup Global Markets Inc., and J.P. Morgan Securities LLC acted as representatives of the several underwriters. Ameriprise entered into an underwriting agreement with them on June 4, 2026 covering the sale of both the 2031 and 2036 senior notes.
Under what SEC registration did Ameriprise Financial offer these senior notes?
The notes were offered under Ameriprise Financial’s shelf registration statement on Form S-3, Registration No. 333-277307. A prospectus dated February 23, 2024 and a prospectus supplement dated June 4, 2026 were filed with the SEC in connection with this offering.
AI-generated analysis. How Rhea-AI works. Not financial advice.
